Comprehensive Analysis of the Glucose Dependent Insulinotropic Polypeptide Agonist Market: Trends, Forecasts, and Key Players
The Glucose Dependent Insulinotropic Polypeptide (GIP) Agonist Market is rapidly evolving as the healthcare sector makes significant strides in managing diabetes and metabolic disorders. GIP, also known as gastric inhibitory polypeptide, is a hormone that plays a crucial role in insulin secretion and glucose metabolism. As the prevalence of type 2 diabetes (T2D) continues to…